Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Biotechnology / Pharmaceutical Services Outsourcing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Biotechnology / Pharmaceutical Services Outsourcing was valued at US$74.2 Billion in 2024 and is projected to reach US$102.2 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Biotechnology / Pharmaceutical Services Outsourcing market.
The growth in the biotechnology and pharmaceutical services outsourcing market is driven by several factors, including the rising demand for cost-efficient drug development processes, technological advancements in research and manufacturing, and the need for expertise in navigating complex regulatory landscapes. Increasing R&D activities, the proliferation of biologics and biosimilars, and the trend toward personalized medicine are further propelling market growth. As pharmaceutical companies focus on core capabilities and innovation, the demand for specialized outsourcing partners to handle clinical trials, manufacturing, and regulatory affairs continues to grow.
How Is the Outsourcing Market Transforming Biotechnology and Pharmaceuticals?
The biotechnology and pharmaceutical services outsourcing market is transforming rapidly, driven by the increasing need for cost reduction, accelerated drug development timelines, and access to specialized expertise. Outsourcing services such as contract research (CRO), contract manufacturing (CMO), and regulatory consulting allow companies to focus on core competencies while leveraging external resources for R&D, clinical trials, and production. This trend is particularly beneficial for small and medium-sized enterprises (SMEs) that lack the infrastructure to conduct end-to-end drug development in-house.
What Role Does Innovation Play in Pharmaceutical Outsourcing?
Innovation plays a critical role in pharmaceutical outsourcing, as service providers continuously adopt advanced technologies such as artificial intelligence (AI), machine learning, and cloud computing to optimize processes and reduce time-to-market. AI-driven platforms are revolutionizing drug discovery and development by analyzing complex biological data, while cloud-based solutions facilitate seamless collaboration between pharmaceutical companies and service providers. Additionally, the integration of digital tools in clinical trials is enhancing patient recruitment, monitoring, and data management, thus improving efficiency and accuracy.
How Are Regulatory Changes Impacting the Pharmaceutical Services Outsourcing Market?
Regulatory changes are significantly impacting the pharmaceutical services outsourcing market, as companies must navigate increasingly complex global regulations for drug approval and compliance. Outsourcing partners with strong regulatory expertise are in high demand to manage submissions, audits, and compliance requirements across multiple markets. The globalization of clinical trials and manufacturing has heightened the need for localized knowledge, compelling pharmaceutical companies to rely on outsourcing firms that can provide tailored regulatory strategies for different regions, including emerging markets.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Report Scope
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as ABmas, Acuitas Therapeutics, Advanced Rx Management, AmerisourceBergen Corporation, Aquaconeer and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Segments:
- Service (Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education, Other Services)
- End-Use (Pharma, Biotech).
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $74.2 Billion |
| Forecasted Market Value (USD) by 2030 | $102.2 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Impact of COVID-19 and a Looming Global Recession
- Biotechnology / Pharmaceutical Services Outsourcing - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Increasing R&D Expenditure by Pharmaceutical Companies Driving Outsourcing Demand
- Rising Focus on Cost Reduction and Efficiency Enhancement in Drug Development
- Growth in Biopharmaceutical Production and Demand for Specialized Services
- Technological Advancements in Drug Discovery, Development, and Manufacturing Processes
- Expansion of Clinical Trials and Need for Regulatory Compliance Boosting CRO Market
- Emergence of New Biologics and Biosimilars Creating Opportunities for CDMOs
- Impact of Globalization and Strategic Partnerships on Outsourcing Market Dynamics
- Increasing Complexity of Drug Molecules and Focus on Niche Therapeutics Driving Outsourcing
- Adoption of Digital and Data-driven Solutions in Pharmaceutical Services Outsourcing
FOCUS ON SELECT PLAYERS:Some of the 46 companies featured in this Biotechnology / Pharmaceutical Services Outsourcing market report include:
- ABmas
- Acuitas Therapeutics
- Advanced Rx Management
- AmerisourceBergen Corporation
- Aquaconeer
- Archbow Consulting
- Aummune
- Avara Pharmaceutical Services, Inc.
- Avior Bio, Inc.
- Bionostra
For more information about this report visit https://www.researchandmarkets.com/r/7ok3mj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
